There has been increasing experimental evidence to suggest that insulin-like growth factor 1 (IGF-I) may be one of the essential regulators in the reproductive system of the rat. IGF-I is synthesized in the hypothalamus and IGF-I immunoreactivity increases during puberty. Consequently we hypothesized that centrally located IGF-I might contribute to the initiation of puberty. Centrally located IGF-I was immunoneutralized to assess this hypothesis. Male Wistar rats, 28 days old, were infused intracerebroventricularly with specific purified IgGs from rabbit IGF-I antiserum (IGF-I-Ab). The intracerebroventricular administration of IGF-I-Ab resulted in a reduction in testicular weight and consequently in delayed pubertal development. There was also a reduction in serum testosterone, pituitary immunoreactive (IR) luteinizing hormone (LH) and serum IR follicle-stimulating hormone (FSH). The accumulation of βLH mRNA was not modified, whereas βFSH mRNA was increased. An increment in the serum growth hormone (GH) levels was also observed. There were no significant alterations in hypothalamic IR growth hormone releasing factor content, although IR somatostatin (SRIH) content was increased by IGF-I-Ab. The body weight gain remained unaltered. As a whole, our study suggests that centrally located IGF-I influences pubertal development, production and release of gonadotropins and supports the finding that endogenous centrally located IGF-I plays a role at the initiation of puberty in the male rat. It also gives support to the physiological role of centrally located IGF-I in the release of GH mediated by hypothalamic SRIH at the initiation of puberty.

1.
Luna AM, Wilson CM, Wibbelsman DM, Brown RC, Nagashima RJ, Hintz RL, Rosenfeld RG: Somatomedins in adolescence: A cross sectional study of the effect of puberty on plasma insulin-like growth factor-I and factor-II levels. J Clin Endocrinol Metab 1983;57:268–271.
2.
Rosenfield R, Furlanetto R: Physiologic induction of puberty increases plasma somatomedin-C. J Pediatr 1985;107:415–418.
3.
Mauras NE, Bizzard R, Link K, Johnson ML, Rogol AD, Veldhuis JD: Augmentation of growth hormone secretion during puberty: Evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 1987;64:596–601.
4.
Hiney JK, Ojeda SR, Dees WL: Insulin-like growth factor-I as a metabolic signal involved in the regulation of female puberty. Neuroendocrinology 1991;54:420–423.
5.
Aguado F, Fernández T, Martinez-Murillo R, Rodrigo J, Cacicedo L, Sánchez-Franco F: Immunocytochemical localization of insulin-like growth factor I in the hypothalamo-hypophyseal system of the adult rat. Neuroendocrinology 1992;56:856–863.
6.
Aguado F, Rodrigo J, Cacicedo L, Mellstrom B: Distribution of insulin-like growth factor-I receptor mRNA in rat brain. Regulation in the hypothalamo-neurohypophyseal system. J Mol Endocrinol 1993;11:231–239.
7.
Hiney JK, Srivastava V, Nyberg CL, Ojeda SR, Les Dees W: Insulin-like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 1996;137:3717–3728.
8.
Dueñas M, Luquin S, Chowen JA, Torres-Aleman I, Naftolin F, Garcia-Segura LM: Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adults rats. Neuroendocrinology 1994;59:528–538.
9.
Bourguignon J-P, Gerard A, Alvarez Gonzalez M-L, Franchimont P: Acute suppression of gonadotropin-releasing hormone secretion by insulin-like growth factor I and subproducts: An age-dependent endocrine effect. Neuroendocrinology 1993;58:525–530.
10.
Ojeda SR, Andrews WW, Advis JP, White SS: Recent advances in the endocrinology of puberty. Endocr Rev 1980;1:229–257.
11.
Ketelslegers JM, Hetzel WD, Sherins RJ, Catt KJ: Developmental changes in testicular gonadotropin receptors: Plasma gonadotropins and plasma testosterone in the rat. Endocrinology 1978;103:212–222.
12.
Abraham GE, Grover PK: Covalent linkage of hormonal haptens to protein carriers for use in radioimmunoassay; in Odell WD, Daughaday WH (eds): Principles of Competitive Protein-Binding Assays. Philadelphia, Lippincott, 1991, pp 134.
13.
Plant TM, Dubey AK: Evidence from the rhesus monkey (Macaca mulatta) for the view that negative feedback control of luteinizing hormone secretion by the testis is mediated by a deceleration of hypothalamic gonadotropin-releasing hormone pulse frequency. Endocrinology 1984;115:2145–2153.
14.
Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego, Academic Press, 1986.
15.
Fernández G, Sánchez-Franco F, De los Frailes MT, Tolón RM, Lorenzo MJ, López J, Cacicedo L: Regulation of somatostatin and growth hormone-releasing factor by gonadal steroids in fetal rat hypothalamic cells in culture. Regul Pept 1992;42:135–144.
16.
Pons S, Torres-Aleman I: Estradiol modulates insulin-like growth factor I receptors and binding proteins in neurons from the hypothalamus. J Neuroendocrinol 1993;5:267–271.
17.
Fernández G, Cacicedo L, Lorenzo MJ, De los Frailes MT, Sánchez-Franco F: Growth hormone-releasing factor production by fetal rat cerebrocortical and hypothalamic cells in primary culture. Endocrinology 1989;125:1991–1998.
18.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Annal Biochem 1987;162:156–159.
19.
Chin WW, Godine JE, Klein DR, Chang AS, Tan LK, Habener JF: Nucleotide sequence of the cDNA encoding the precursor of the β subunit of rat lutropin. Proc Natl Acad Sci USA 1983;80:4649–4653.
20.
Gharib SD: Isolation and characterization of the gene encoding the β-subunit of rat follicle-stimulating hormone. DNA 1989;8:339–349.
21.
Seeburg PH, Shine J, Martial JA, Baxter JD, Goodman HM: Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature 1977;270:486–494.
22.
Tolón RM, Sánchez-Franco F, De los Frailes MT, Lorenzo MJ, Cacicedo L: Effect of potassium-induced depolarization on somatostatin gene expression in cultured fetal rat cerebrocortical cell. J Neurosci 1994;14:1053–1059.
23.
Knorr DW, Vanha-Perttula T, Lipsett MB: Structure and function of rat testis through pubescence. Endocrinology 1970;86:1298–1305.
24.
Bourguignon J-P, Franchimont P: Puberty-related increase in episodic LHRH release from rat hypothalamus in vitro. Endocrinology 1984;114:1941–1943.
25.
Bourguignon J-P, Gerard A, Alvarez Gonzalez M-L, Purnelle G, Franchimont P: Endogenous glutamate involvement in pulsatile secretion of gonadotropin-releasing hormone: Evidence from effect of glutamine and developmental changes. Endocrinology 1995;136:911–916.
26.
Zhen S, Zakaria M, Wolfe A, Radovick S: Regulation of gonadotropin-releasing hormone (GnRH) gene expression by insulin-like growth factor I in a cultured GnRH expressing neuronal cell line. Mol Endocrinol 1997;11:1145–1155.
27.
Haisenleder DJ, Katt JA, Ortolano GA, El-Gewely MR, Duncan JA, Dee C, Marshall JC: Influence of gonadotropin-releasing hormone pulse amplitude, frequency and treatment duration on the regulation of luteinizing hormone (LH) subunit messenger ribonucleic acids and LH secretion. Mol Endocrinol 1988;2:338–343.
28.
Bergendahl M, Perheentupa A, Huntaniemi I: Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male rats. J Endocrinol 1989;121:409–417.
29.
Drouin J, Labrie F: Selective effect of androgens on LH and FSH release in anterior pituitary cells in culture. Endocrinology 1976;98:1528–1534.
30.
Iliff-Sizemore SA, Ortolano GA, Haisenleder DJ, Dalkin AC, Krueger KA, Marshall JC: Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude. Endocrinology 1990;127:2876–2883.
31.
Catt KJ, Dufau ML: Gonadotropic hormones: Biosynthesis, secretion, receptors and actions; in Yen SSC, Jaffe RB (eds): Reproductive Endocrinology. Philadelphia, Saunders, 1991, pp 105–155.
32.
Kirk SE, Dalkin AC, Yasin M, Haisenleder DJ, Marshall JC: Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: A mechanism for differential gonadotrope function. Endocrinology 1994;135:876–880.
33.
Mittler JC: Androgen effects on follicle-stimulating hormone (FSH) secretion in organ culture. Neuroendocrinology 1974;16:265–272.
34.
Bhasin S, Fielder TJ, Swerdloff RS: Testosterone selectively increases serum follicle-stimulating hormonal (FSH) but not luteinizing hormone (LH) in gonadotropin-releasing hormone antagonist-treated male rats: Evidence for differential regulation of LH and FSH secretion. Biol Reprod 1987;37:55–59.
35.
Arslan M, Weinbauer GF, Khan SA, Nieschlag E: Testosterone and dehydrotestosterone, but not estradiol, selectively maintain pituitary and serum follicle-stimulating hormone in gonadotropin-releasing hormone antagonist treated male rats. Neuroendocrinology 1989;49:395–401.
36.
Weirs J, Crowley WF, Halvorson LM, Jameson JL: Perifusion of rat pituitary cells with gonadotropin releasing hormone, activin, inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 1993;132:2307–2311.
37.
Bilezikjian LM, Corrigan AZ, Blount AL, Vale WW: Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. Endocrinology 1996;137:4277–4284.
38.
Tannenbaum GS: Insulin-like growth factors: A role in growth hormone negative feedback and body weight regulation via brain. Science 1983;220:77–79.
39.
Sato M, Frohman LA: Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and SRIH gene expression in GH-deficient dwarf rats. Endocrinology 1993;133:793–799.
40.
Frohman LA, Downs TR, Chomczynski P: Regulation of growth hormone secretion. Front Neuroendocrinol 1992;13:344–406.
41.
Fernández-Vázquez G, Cacicedo L, De los Frailes MT, Lorenzo MJ, Tolón R, Sánchez-Franco F: Growth hormone-releasing factor regulation by somatostatin, growth hormone and insulin-like growth factor I in fetal rat hypothalamic-brain stem cell cocultures. Neuroendocrinology 1993;58:655–665.
42.
Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL: Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest 1994;94:138–145.
43.
Harel Z, Tannenbaum GS: Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion. Endocrinology 1992;131:758–764.
44.
Spencer GSG, Berry C, Hodgkinson SC, Bass JJ: On the neuroendocrine role of insulin-like growth factors 1 and 2 in the regulation of growth hormone secretion. Mol Cell Neurosci 1993;4:538–542.
45.
Melmed S, Yamashita S, Yamasaki H, Fagin J, Namba H, Yamamoto H, Weber M, Morita S, Webster J, Prager D: IGF-I receptor signalling: Lessons from the somatotroph. Recent Prog Horm Res 1996;51:189–216.
46.
Gick GG, Bancroft C: Glucocorticoid stimulation of growth hormone messenger ribonucleic acid levels in GH3 cells is inhibited by calcium but not by somatostatin. Endocrinology 1987;120:1986–1990.
47.
Barinaga M, Bilezikjian LM, Vale WW, Rosenfeld MG, Evans RM: Independent effects of growth hormone releasing factor on growth hormone release and gene transcription. Nature 1985;314:279–281.
48.
Borski RJ, Tsai W, DeMott-Friberg R, Barkan AL: Regulation of somatic growth and the somatotropic axis by gonadal steroids: Primary effect on insulin-like growth factor I gene expression and secretion. Endocrinology 1996;137:3253–3259.
49.
Maiter D, Underwood LE, Maes M, Davenport ML, Ketelslegers JM: Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 1988;123:1053–1059.
50.
López-Fernández J, Sánchez-Franco F, Velasco B, Tolón RM, Pazos F, Cacicedo L: Growth hormone induces somatostatin and insulin-like growth factor I gene expression in the cerebral hemispheres of aging rats. Endocrinology 1996;137:4384–4391.
51.
Lanzi R, Tannenbaum GS: Time course and mechanism of growth hormone’s negative feedback effect on its own spontaneous release. Endocrinology 1992;130:788–790.
52.
Jansson J, Eden S, Isaksson O: Site of action of testosterone and estradiol on longitudinal bone growth. Am J Physiol 1983;244:E135-E140.
53.
Sandstedt J, Ohlsson C, Norjavaara E, Nilsson J, Tornell J: Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. Endocrinology 1994;135:2574–2580.
54.
Gabrielsson BG, Carmignac DF, Flavell DM, Robinson IACF: Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology 1995;136:209–217.
55.
Woodward DJ: A re-evaluation of the anabolic effect of testosterone in rats: Interactions with gonadectomy, adrenalectomy and hypophysectomy. Acta Endocrinol (Copenh) 1993;128:473–477.
56.
Metzger DL, Kerrigan JR: Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: Evidence for independent actions of estrogen and androgen. J Clin Endocrinol Metab 1993;76:1147–1152.
57.
Metzger DL, Kerrigan JR, Rogol AD: Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans. Mechanisms of androgen and estrogen action. Trends Endocrinol Metab 1994;5:290–296.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.